Visine TotalityMulti Symptom Relief (Johnson & Johnson Consumer Inc.)


Welcome to the PulseAid listing for the Visine Totality drug offered from Johnson & Johnson Consumer Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Johnson & Johnson Consumer Inc.
NON-PROPRIETARY NAME: Glycerin, Hypromelloses, Polyethylene Glycol 400, Tetrahydrozoline Hydrochloride, and Zinc Sulfate
SUBSTANCE NAME: GLYCERIN; HYPROMELLOSES; POLYETHYLENE GLYCOL 400; TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE, UNSPECIFIED FORM
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: OPHTHALMIC
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2011-08-23
END MARKETING DATE: 0000-00-00


Visine Totality Multi Symptom Relief HUMAN OTC DRUG Details:

Item DescriptionVisine Totality Multi Symptom Relief from Johnson & Johnson Consumer Inc.
LABELER NAME: Johnson & Johnson Consumer Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2.5; 3.6; 11.28; .5; 2.5(mg/mL; mg/mL; mg/mL; mg/mL; mg/mL)
START MARKETING DATE: 2011-08-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42002-209_5a553211-7532-4046-901d-77d9e005937d
PRODUCT NDC: 42002-209
APPLICATION NUMBER: part349

Other GLYCERIN; HYPROMELLOSES; POLYETHYLENE GLYCOL 400; TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE, UNSPECIFIED FORM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Johnson & Johnson Consumer Inc.Visine Totality